来自母细胞的MIF极化Th17细胞,驱动肺腺癌的进展
Qianqian Peng1, Xiong Ye2, Xingyi Xu1
1Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cancer immunology, immunotherapy : CII
|March 14, 2026
概括
乳腺细胞 (MCs) 通过通过巨细胞迁移抑制因子 (MIF) 将Th17细胞两极化,促进肺腺癌 (LUAD) 的进展. 针对MC-MIF-Th17轴为LUAD治疗提供了一个新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症微环境 癌症微环境
背景情况:
- 肺腺癌 (LUAD) 的进展涉及复杂的瘤微环境 (TME) 相互作用.
- 巨细胞 (MCs) 存在于瘤中,但其精确的免疫调节作用尚未完全理解.
研究的目的:
- 为了研究巨细胞 (MCs) 和Th17细胞在肺腺癌 (LUAD) 的瘤微环境中的作用.
- 阐明MCs影响LUAD进展的机制,并确定潜在的治疗点.
主要方法:
- 对LUAD组织的血液学参数和多重免疫组织化学 (mIHC) 的回顾性分析.
- 单细胞RNA测序和体外/体内功能测试的整合.
- 评估巨细胞 (MC) 激活,Th17细胞极化和瘤细胞行为,在小鼠模型中进行药理干预.
主要成果:
- 在LUAD患者中观察到升高的IL-17水平和MC透和Th17细胞丰度之间的正相关性.
- 在LUAD组织中,发现MCs和Th17细胞非常接近,特别是在周区域,与疾病进展相关.
- 确定了MC-MIF-Th17轴,其中MCs分泌巨细胞迁移抑制因子 (MIF) 来促进Th17细胞极化,增强瘤细胞的增殖,迁移和入侵.
结论:
- 巨细胞 (MCs) 通过巨细胞迁移抑制因子 (MIF) 介导的Th17细胞两极化显著促进LUAD的进展.
- MC-MIF-Th17轴代表了肺腺癌 (LUAD) 治疗的新且有前途的治疗标.
更多相关视频
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
32.3K
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
3.2K
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
